Daily Treatment With the Glutamate Receptor Antagonist Mk-801 Retards Behavioral and Neurochemical Recovery From Partial 6-hydroxydopamine Lesions of the Substantia Nigra
Year: 1995
Type: article
Source: Behavioural Pharmacology
Institution: Concordia University
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2079221747
